Cargando…

Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma

SIMPLE SUMMARY: The cure rate of Hodgkin lymphoma is currently higher than 80% for almost all stages at diagnosis. Despite the particularly good efficacy of chemotherapy and radiotherapy, some late complications such as cardiovascular disease and second malignancies can occur in a small proportion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vellemans, Hélène, André, Marc P. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345175/ https://www.ncbi.nlm.nih.gov/pubmed/34359646 http://dx.doi.org/10.3390/cancers13153745

Ejemplares similares

Managing advanced stage Hodgkin lymphoma
por: Saikia, TK
Publicado: (2015)

Emerging treatment options for the management of Hodgkin’s lymphoma: clinical utility of nivolumab
por: Bond, David A, et al.
Publicado: (2017)

Advanced stage Hodgkin Lymphoma: patient management
por: Gini, Guido, et al.
Publicado: (2020)

Recent advances in the management of Hodgkin lymphoma
por: Villasboas, Jose C., et al.
Publicado: (2016)

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
por: Lockney, Natalie A., et al.
Publicado: (2020)

New Treatment Options in Advanced Stage Follicular Lymphoma
por: Hübel, Kai, et al.
Publicado: (2018)

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
por: Fedele, Roberta, et al.
Publicado: (2015)

Advances in the treatment of Hodgkin's lymphoma (Review)
por: Che, Yuxuan, et al.
Publicado: (2023)

Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma
por: Novakovic, Barbara Jezersek
Publicado: (2015)

Radiotherapy for Non-Hodgkin’s lymphoma: still standard practice and not an outdated treatment option
por: Zimmermann, Michel, et al.
Publicado: (2016)

Treatment results in advanced stage Hodgkin's lymphoma: A retrospective study
por: Jain, H, et al.
Publicado: (2015)

Options for first line therapy of Hodgkin lymphoma
por: Longley, Jemma, et al.
Publicado: (2019)

Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review
por: Zilioli, Vittorio Ruggero, et al.
Publicado: (2023)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

Novel Salvage Therapy Options for Initial Treatment of Relapsed/Refractory Classical Hodgkin’s Lymphoma: So Many Options, How to Choose?
por: Takiar, Radhika, et al.
Publicado: (2022)

Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances
por: Derenzini, Enrico, et al.
Publicado: (2011)

Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
por: Iqbal, Nida, et al.
Publicado: (2014)

PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one?
por: Rossi, Cédric, et al.
Publicado: (2019)

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
por: De Re, Valli, et al.
Publicado: (2022)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist
por: Schmittlutz, Katrin, et al.
Publicado: (2021)

Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies
por: Mohty, Razan, et al.
Publicado: (2021)

HLA-G Expression and Role in Advanced-Stage Classical Hodgkin Lymphoma
por: Caocci, G., et al.
Publicado: (2016)

Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
por: Feugier, Pierre, et al.
Publicado: (2019)

Hodgkin's Lymphoma: A Review of Neurologic Complications
por: Grimm, Sean, et al.
Publicado: (2011)

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy
por: Avilés, Agustin, et al.
Publicado: (2018)

The Evolving Role of Radiotherapy in Early Stage Hodgkin’s Lymphoma
por: Ricardi, Umberto, et al.
Publicado: (2014)

Current advances in Hodgkin’s lymphoma
por: Vadakara, Joseph, et al.
Publicado: (2019)

Bendamustine in the treatment of non-Hodgkin’s lymphomas
por: Hagemeister, Fredrick, et al.
Publicado: (2009)

Rituximab in the treatment of non-Hodgkin’s lymphoma
por: Hauptrock, Beate, et al.
Publicado: (2008)

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017)

Molecular biology of Hodgkin lymphoma
por: Weniger, Marc A., et al.
Publicado: (2021)

Consolidation radiotherapy for advanced-stage aggressive B-cell non-Hodgkin lymphoma: A systematic review and meta-analysis
por: Yap, Ernie, et al.
Publicado: (2017)

Systematic review of perchloroethylene and non-Hodgkin's lymphoma
por: Goodman, Julie E., et al.
Publicado: (2022)

Advances in the treatment of Hodgkin lymphoma: Current and future approaches
por: Ullah, Fauzia, et al.
Publicado: (2023)

Advanced Hodgkin Lymphoma: a New Era of Therapy
por: Dann, Eldad J.
Publicado: (2014)

Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
por: Chao, Mark P
Publicado: (2013)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
por: Richardson, S. E., et al.
Publicado: (2011)

Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
por: Pinochet, Pierre, et al.
Publicado: (2021)

An update on the management of peripheral T-cell lymphoma and emerging treatment options
por: Phillips, Adrienne A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3juhv937pidanod3boo9fclsc4